Project description:Trial described in Lancet. 2006 Sep 2;368(9538):855-63. Rheumatoid arthritis patients were treated with chaperonin 10, with a dose of 10 mg rCpn10 i.v. twice weekly for 56 days. Blood samples were collected before and after treatment. Microarray analysis described in Hirata et al., Early pregnancy factor, chaperonin 10 and rheumatoid arthritis; the story unravels. J Transl Sci 2018.
Project description:Investigation of differentially regulated genes in deletion of Vp1 compared to the wild-type. VP1 is a signaling peptide. Its characterization is described in Cuevas et al 2019 ADD TITLE AND REF